Comparison of low fixed dose versus standard-dose rituximab to treat thrombotic thrombocytopenic purpura in the acute phase and preemptively during remission

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Comparison of low fixed dose versus standard-dose rituximab to treat thrombotic thrombocytopenic purpura in the acute phase and preemptively during remission'. Together they form a unique fingerprint.

Medicine & Life Sciences